BrownMorgan Stanley Wealth ManagementWichitaKansas$250K$1.2B$500K-5M$500K-2MTed ChartierFCS Private Wealth Management | Wells Fargo Advisors Financial NetworkLeawoodKansas$1M$2.8B$1-18M$800K-14MCole HelbertMerrill Wealth ManagementLeawoodKansas$2M$510M$5-50M$5-25MPat AubryMorgan Stanley Wealth ManagementLeawoodKansas$500K$1.1B$1-7M$250K-5MPaul AttwaterMorgan Stanley Wealth ManagementWichitaKansas$1.5M$1.2B$4-50M$2-15MKristie SvejdaRBC Wealth ManagementLeawoodKansas$500K$280M$500K-3M$750K-5MJoanna BramlettEdward JonesOverland ParkKansas$750K$205M$1.4-3.5M$800K-2.7MCharles Schorgl Jr.Intellego Investment Partners | Wells Fargo Advisors Financial NetworkLeawoodKansas$500K$746M$3-8M$1-8MThane BernbeckNorthwestern MutualTopekaKansas$250K$232M$1-5M$500K-2.5MJon LewisEdward JonesMulvaneKansas$0$208M$500K-3M$250K-2MKevin BlickMerrill Wealth ManagementLeawoodKansas$750K$1.5B$1-10M$850K-10MRobin HarneyStifelOverland ParkKansas$100K$421M$250K-22M$250K-22MDan CroweMerrill Wealth ManagementLeawoodKansas$1M$2.1B$3-12M$2-10MMatt SayersFCS Private Wealth Management | Wells Fargo Advisors Financial NetworkLeawoodKansas$1M$2.8B$2-10M$1-5MTravis MusgraveMerrill Wealth ManagementLexingtonKentucky$3M$1.5B$5-150M$3-100MDrew WatsonAmeriprise Financial ServicesOwensboroKentucky$100K$1.5B$1.5-20M$719K-3.5MGreg CouchMeridian Wealth ManagementLexingtonKentucky$1M$4.1B$1-10M$1-10MMitch SettleBairdOwensboroKentucky$150K$1.2B$1-5M$800K-2.5MMorgan FisterMorgan Stanley Wealth ManagementLexingtonKentucky$2M$1.7B$3.5-25M$3-35MPhilip W
When something goes wrong with a compounded medication, there are legal frameworks for accountability and recourse
Plateaus, discontinuation, and what happens next Weight-loss plateaus pauses in your weight loss are common during GLP-1 treatment
Mild to moderate nausea occurs in roughly 20 to 30 percent of patients and typically peaks between days two and four before improving
Certificate of Analysis Frequently Asked Questions L-Carnitine is a naturally occurring amino acid derivative essential for transporting long-chain fatty acids into mitochondria for beta-oxidation (the carnitine shuttle)
Not persisting with medication is a well known phenomenon with other conditions, such as type 2 diabetes, chronic obstructive pulmonary disease and hypertension
